Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression
Open Access
- 6 January 2023
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-10
Abstract
Microorganisms living at many sites in the human body compose a complex and dynamic community. Accumulating evidence suggests a significant role for microorganisms in cancer, and therapies that incorporate bacteria have been tried in various types of cancer. We previously demonstrated that cupredoxin azurin secreted by the opportunistic pathogen Pseudomonas aeruginosa, enters human cancer cells and induces apoptotic death1–4. However, the physiological interactions between P. aeruginosa and humans and their role in tumor homeostasis are largely unknown. Here, we show that P. aeruginosa upregulated azurin secretion in response to increasing numbers of and proximity to cancer cells. Conversely, cancer cells upregulated aldolase A secretion in response to increasing proximity to P. aeruginosa, which also correlated with enhanced P. aeruginosa adherence to cancer cells. Additionally, we show that cancer patients had detectable P. aeruginosa and azurin in their tumors and exhibited increased overall survival when they did, and that azurin administration reduced tumor growth in transgenic mice. Our results suggest host–bacterial symbiotic mutualism acting as a diverse adjunct to the host defense system via inter-kingdom communication mediated by the evolutionarily conserved proteins azurin and human aldolase A. This improved understanding of the symbiotic relationship of bacteria with humans indicates the potential contribution to tumor homeostasis.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB023924)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA252370)
This publication has 83 references indexed in Scilit:
- Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United StatesJNCI: Journal of the National Cancer Institute, 2012
- Escherichia coli Nissle 1917 Targets and Restrains Mouse B16 Melanoma and 4T1 Breast Tumors through Expression of Azurin ProteinApplied and Environmental Microbiology, 2012
- Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesisMolecular Cancer, 2012
- Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopyInternational Journal of Nanomedicine, 2011
- Evolutionary transitions in bacterial symbiosisProceedings of the National Academy of Sciences, 2011
- The Bacterial Protein Azurin Enhances Sensitivity of Oral Squamous Carcinoma Cells to Anticancer DrugsYonsei Medical Journal, 2011
- Toward a better analysis of secreted proteins: the example of the myeloid cells secretomeProteomics, 2007
- Unique complex between bacterial azurin and tumor-suppressor protein p53Biochemical and Biophysical Research Communications, 2005
- Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.Journal of Clinical Investigation, 1992
- CONTRIBUTION TO THE KNOWLEDGE OF SARCOMAAnnals of Surgery, 1891